Wandercraft raises €39.7M Series C round

20 January 2022· Paris, France· health, robotics, ai, exoskeletons, software_hardware, b2b, b2c

To continue development and launch of the new Personal Exoskeleton for outdoor and home use, and to accelerate the deployment of Atalante, its rehabilitation exoskeleton, in the USA.

Investors

LeadQuadrant Management
Also participating
BpifranceEurazeoMACSFLBO FranceMutuelles ImpactXAngeCemag InvestAG2R LA MONDIALEMalakoff HumanisSofiouest

About Wandercraft

Stage
Series D
Headquarters
Paris, France
Founded
2012
Team Size
51–200
Sectors
healthroboticsaiexoskeletonssoftware_hardwareb2bb2c

Source: https://www.firstwordhealthtech.com/node/1922579